
Related Sciences (RS) is a data science-driven drug foundry that uses a proprietary predictive AI platform and a decentralized R&D model to identify and develop the best new drug creation opportunities from millions of possibilities. RS integrates advances in biology, engineering, and machine learning to build an evergreen pipeline of new medicines with exceptional clinical and economic promise. Their business model centralizes and systematizes world-class drug discovery capabilities, investing in portfolios called "constellations" that optimize risk-reward and R&D synergies. RS leverages a fully virtual, decentralized team science approach to reduce R&D costs by over 40%, while collaborating with top global research service providers and technology partners to maximize drug discovery success. The company is positioned as a pioneer in AI-enabled, data-driven drug discovery with a scalable, capital-efficient model and a strong leadership team of biotech, data science, and venture capital veterans.

Related Sciences (RS) is a data science-driven drug foundry that uses a proprietary predictive AI platform and a decentralized R&D model to identify and develop the best new drug creation opportunities from millions of possibilities. RS integrates advances in biology, engineering, and machine learning to build an evergreen pipeline of new medicines with exceptional clinical and economic promise. Their business model centralizes and systematizes world-class drug discovery capabilities, investing in portfolios called "constellations" that optimize risk-reward and R&D synergies. RS leverages a fully virtual, decentralized team science approach to reduce R&D costs by over 40%, while collaborating with top global research service providers and technology partners to maximize drug discovery success. The company is positioned as a pioneer in AI-enabled, data-driven drug discovery with a scalable, capital-efficient model and a strong leadership team of biotech, data science, and venture capital veterans.